3-acetoxy-6-methyl-benzofuran | 60770-30-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并呋喃
• 英文名称: 3-acetoxy-6-methyl-benzofuran
• 英文别名: 6-methyl-1-benzofuran-3-yl acetate；6-Methyl-3-acetoxybenzofuran；(6-methyl-1-benzofuran-3-yl) acetate
• CAS: 60770-30-1
• 化学式: C₁₁H₁₀O₃
• 分子量: 190.199
• InChiKey: JPCIXYIWFQDYCL-UHFFFAOYSA-N

物化性质

• 熔点：
  38 °C(Solv: methanol (67-56-1); water (7732-18-5))
• 沸点：
  163.5 °C(Press: 17 Torr)
• 密度：
  1.186±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.18
• 拓扑面积：
  39.4
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  3-acetoxy-6-methyl-benzofuran 以 盐酸 、 甲醇 、 水 为溶剂， 反应 1.5h， 以to give 6-methyl-2,3-dihydro-1-benzofuran-3-one as a white solid (2.5 g, 82%)的产率得到6-甲基-3(2H)-苯并呋喃酮
  参考文献：
  名称：

  HETEROCYCLIC COMPOUNDS FOR THE INHIBITION OF PASK

  摘要：

  本文披露了新的杂环化合物和组合物，并将其应用作药物治疗疾病。还提供了抑制人类或动物主体中PAS激酶（PASK）活性的方法，以治疗糖尿病等疾病。

  公开号：

  US20120232056A1
• 作为产物：
  描述：

  O-Carboxymethyl-4-methylsalicylsaeure 、 乙酸酐 在 sodium acetate 、 溶剂黄146 作用下， 反应 4.0h， 生成 3-acetoxy-6-methyl-benzofuran
  参考文献：
  名称：

  Synthesis, antibacterial activity, and quantitative structure–activity relationships of new (Z)-2-(nitroimidazolylmethylene)-3()-benzofuranone derivatives

  摘要：

  A new series of (Z)-2-(1-methyl-5-nitroimidazole-2-ylmethylene)-3(2H)-benzofuranones (11a-p) and (Z)-2-(1-methyl-4-nitroimidazole-5-ylmethylene)-3(2H)-benzofuranones (12a-m) were synthesized and assayed for their antibacterial activity against Gram-positive and Gram-negative bacteria. Most of the 5-nitroimidazole analogues (11a-p) showed a remarkable inhibition of a wide spectrum of Gram-positive bacteria (Staphylococcus aureus, Streptococcus epidermidis, MRSA, and Bacillus subtilis) and Gram-negative Klebsiella pneumoniae, whereas 4-nitroimidazole analogues (12a-m) were not effective against selected bacteria. The quantitative structure-activity relationship investigations were applied to find out the correlation between the experimentally evaluated activities with various parameters of the compounds studied. The QSAR models built in this work had reasonable predictive power and could be explained by the observed trends in activities. (C) 2007 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2007.09.062

文献信息

• Substituted quinoxaline carboxylic acids for the inhibition of PASK
  申请人：McCall John M.

  公开号：US08912188B2

  公开（公告）日：2014-12-16

  Disclosed herein are substituted quinoxaline carboxylic acids of Formula (I): and compositions thereof, which may be useful as inhibitors of PAS Kinase (PASK) activity in a human or animal for the treatment of diseases such as diabetes mellitus.

  本文公开了式(I)的取代喹喔啉羧酸及其组合物，可能作为治疗糖尿病等疾病中人类或动物PAS激酶（PASK）活性抑制剂。
• CAGNIANT P.; KIRSCH G., C. R. ACAD. SCI <CHDC-AQ>, 1976, C 282, NO 21, 993-996
  作者：CAGNIANT P.、 KIRSCH G.

  DOI：——

  日期：——
• TURAN-ZITOUNI G.; FULCRAND P., CHIM. ACTA TURC., 13,(1985) N 3, 403-412
  作者：TURAN-ZITOUNI G.、 FULCRAND P.

  DOI：——

  日期：——
• US8912188B2
  申请人：——

  公开号：US8912188B2

  公开（公告）日：2014-12-16
• [EN] HETEROCYCLIC COMPOUNDS FOR THE INHIBITION OF PASK<br/>[FR] COMPOSÉS HÉTÉROCYCLIQUES POUR L'INHIBITION DE LA KINASE DE DOMAINE PAS (PASK)
  申请人：BIOENERGENIX

  公开号：WO2012119046A2

  公开（公告）日：2012-09-07

  Disclosed herein are new heterocyclic compounds and compositions and their application as pharmaceuticals for the treatment of disease. Methods of inhibiting PAS Kinase (PASK) activity in a human or animal subject are also provided for the treatment of diseases such as diabetes mellitus.